Published in Qual Health Care on March 01, 1995
Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res (2017) 0.81
The ideal: enemy of the useful? Qual Health Care (1995) 0.75
The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health (1989) 5.20
Needs assessment, priority setting, and contracts for health care: an economic view. BMJ (1991) 2.74
An economic view of high compliance as a screening objective. BMJ (1994) 2.56
Can health visitors prevent fractures in elderly people? BMJ (1992) 2.25
Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess (2004) 29.45
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60
Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature (1995) 4.24
Midwife managed delivery unit: a randomised controlled comparison with consultant led care. BMJ (1994) 4.23
Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet (1996) 3.77
Economic evaluation of robot-assisted hysterectomy: a cost-minimisation analysis. BJOG (2014) 3.25
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A (2001) 3.23
Paying general practitioners: shedding light on the review of health services. J R Coll Gen Pract (1989) 2.83
An economic view of high compliance as a screening objective. BMJ (1994) 2.56
The future of health care in Canada. BMJ (2001) 2.53
Are cost of injury studies useful? Inj Prev (2000) 2.50
Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study. BMJ (1992) 2.27
Use of systematic reviews of randomised trials by Australian neonatologists and obstetricians. Med J Aust (1998) 2.18
The pharmacokinetics of combination therapy with nelfinavir plus nevirapine. AIDS (1998) 2.16
Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A (1994) 2.14
Assessing the costs of assisted reproductive techniques. Br J Obstet Gynaecol (1996) 2.07
A case control study of infection with an epidemic strain of multiresistant Salmonella typhimurium DT104 in England and Wales. Commun Dis Rep CDR Rev (1994) 2.04
A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun (1998) 2.02
Comparison of ventricular ectopic activity during 24-hour monitoring and exercise testing in patients with coronary heart disease. N Engl J Med (1975) 1.98
Using discrete choice modelling in priority setting: an application to clinical service developments. Soc Sci Med (2000) 1.97
The cost of cervical cancer screening provided by a women's health nurse. Aust J Public Health (1992) 1.94
Chiropody and the QALY: a case study in assigning categories of disability and distress to patients. Health Policy (1991) 1.89
Computerised protocols for laboratory investigation and their effect on use of medical time and resources. J Clin Pathol (1992) 1.87
Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci U S A (1995) 1.86
The role of physiotherapy in the management of acute neck sprains following road-traffic accidents. Arch Emerg Med (1989) 1.83
Effectiveness of cognitive-behavioural family intervention in reducing the burden of care in carers of patients with Alzheimer's disease. Br J Psychiatry (2000) 1.81
Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS (1997) 1.65
Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J (2000) 1.58
Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant (2001) 1.55
Age-restricted cervical screening: HPV testing at age 50 identifies a high risk group for cervical disease. Int J Gynecol Cancer (2002) 1.55
The organisms reported to cause infective myocarditis and pericarditis in England and Wales. J Infect (1996) 1.54
General practice management of illicit drug users in Scotland: a national survey. Addiction (2003) 1.52
The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. Clin Invest Med (2001) 1.52
Tools of the trade: a comparative analysis of approaches to priority setting in healthcare. Health Serv Manage Res (2003) 1.51
Should QALYs be programme-specific? J Health Econ (1988) 1.51
Crystal structure of the phosphatidylinositol-specific phospholipase C from Bacillus cereus in complex with myo-inositol. EMBO J (1995) 1.49
Recruitment methods for screening programmes: trial of an improved method within a regional osteoporosis study. BMJ (1993) 1.49
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev (2001) 1.48
Cytology and mesenchymal pathology: how far will we go? Am J Clin Pathol (1996) 1.46
A systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma. Br J Sports Med (2008) 1.46
Hormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol Reprod Biol (1995) 1.45
Twenty-five years of programme budgeting and marginal analysis in the health sector, 1974-1999. J Health Serv Res Policy (2001) 1.44
Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease. Cochrane Database Syst Rev (2001) 1.44
The veil of experience: do consumers prefer what they know best? Health Econ (2000) 1.43
Utilisation as a measure of equity: weighing heat? J Health Econ (1991) 1.43
Comparing different methods of assessing body composition in end-stage renal failure. Kidney Int (2000) 1.42
Multiple myeloma: the bone marrow microenvironment and its relation to treatment. Br J Biomed Sci (2013) 1.42
Using economics to prioritize research: a case study of randomized trials for the prevention of hip fractures due to osteoporosis. J Health Serv Res Policy (1996) 1.41
Cost of treating stroke in an Irish teaching hospital. Ir Med J (2003) 1.40
Creativity and sacrifice: two sides of the coin. A reply to David Seedhouse. Health Care Anal (1997) 1.40
Pulmonary embolism in pregnancy: is nuclear medicine imaging still a valid option? Ir Med J (2008) 1.40
Serotonin infusions inhibit sensory input from the dural vasculature. Cephalalgia (1999) 1.40
Falsely reassuring pulse oximetry in the presence of severe hypoxia. Can J Anaesth (1997) 1.39
Rapid on-site evaluation of axillary fine-needle aspiration cytology in breast cancer. Br J Surg (2012) 1.39
Bone mineral density measurements: are they worth while? J R Soc Med (1996) 1.39
Mother care for children in hospital. Br Med J (Clin Res Ed) (1984) 1.39
A herb for migraine. Nurs Times (2002) 1.38
An economic evaluation of early versus late referral of patients with progressive renal insufficiency. Am J Kidney Dis (2001) 1.36
Gene expression profiling in the post-mortem human brain--no cause for dismay. J Chem Neuroanat (2001) 1.36
Caveat emptor or blissful ignorance? Patients and the consumerist ethos. Soc Sci Med (1991) 1.35
An improved system for the assay of stimulation in mouse mixed leucocyte cultures. J Immunol Methods (1974) 1.35
Growth stimulation of human diploid fibro-blasts by the tumor promoter, 12-0-tetradecanoly-phorbol-13-acetate. Int J Cancer (1974) 1.33
Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance. Health Econ (1996) 1.32
Menopausal symptoms in Australian women. Med J Aust (1993) 1.32
Acupressure and prevention of nausea and vomiting during and after spinal anaesthesia for caesarean section. Br J Anaesth (2000) 1.29
Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J Biol Chem (2001) 1.27
Neural basis of the emotional Stroop interference effect in major depression. Psychol Med (2007) 1.26
Secondary glaucoma after paediatric cataract surgery. Br J Ophthalmol (2007) 1.25
HIV infection and AIDS in England and Wales: general practitioners' workload and contact with patients. Br J Gen Pract (1990) 1.25
Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J (1991) 1.24
Bacterial phosphatidylinositol-specific phospholipase C: structure, function, and interaction with lipids. Biochim Biophys Acta (1999) 1.23
Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. J Urol (2004) 1.23
Day hospitals for the elderly: utilisation and performance. Community Med (1987) 1.23
Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project. Health Technol Assess (2010) 1.22
Interaction of sildenafil and indinavir when co-administered to HIV-positive patients. AIDS (1999) 1.21
Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants? Clin Nephrol (2003) 1.21
Remuneration of Soviet medical personnel. Br Med J (Clin Res Ed) (1987) 1.20
Magnetic resonance imaging in the assessment of rheumatoid arthritis--a comparison with plain film radiographs. Br J Rheumatol (1991) 1.18
Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy. Gene Ther (1999) 1.17
Do obstetric complications explain high caesarean section rates among women over 30? A retrospective analysis. BMJ (2001) 1.17
Helicopters, hearts and hips: using willingness to pay to set priorities for public sector health care programmes. Soc Sci Med (1998) 1.17
The effect of endotoxin on murine stem cells. J Cell Physiol (1973) 1.16
Inducible expression of the P, V, and NP genes of the paramyxovirus simian virus 5 in cell lines and an examination of NP-P and NP-V interactions. J Virol (1995) 1.15
Assessing women's preferences for intrapartum care. Birth (2001) 1.15
An estimate of the proportion of diarrhoeal disease episodes seen by general practitioners attributable to rotavirus in children under 5 y of age in England and Wales. Acta Paediatr Suppl (1999) 1.14
Involving consumers in health care decision making. Health Care Anal (1995) 1.14
Health economic evaluation. J Epidemiol Community Health (2002) 1.13
Economics, public health and health care purchasing: the Tayside experience of programme budgeting and marginal analysis. J Health Serv Res Policy (1996) 1.11
The cost of diabetes. Diabet Med (1989) 1.11
Applications of cost-benefit analysis to health care. Departures from welfare economic theory. J Health Econ (1987) 1.11
An evidence synthesis of qualitative and quantitative research on component intervention techniques, effectiveness, cost-effectiveness, equity and acceptability of different versions of health-related lifestyle advisor role in improving health. Health Technol Assess (2011) 1.11
Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science. Pharmacoeconomics (1999) 1.10
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev (2005) 1.09
The cost of medicines in the United Kingdom. A survey of general practitioners' opinions and knowledge. Pharmacoeconomics (1997) 1.09
Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J Immunol (1997) 1.08
Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy. Gene Ther (2001) 1.07
Stress response decreases NF-kappaB nuclear translocation and increases I-kappaBalpha expression in A549 cells. J Clin Invest (1997) 1.07